Loading
A phase 2 trial of Carmustine in hodgkin lymphoma and non-hodgkin lymphoma, run by VIVUS LLC, now recruiting.
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma is a phase 2 interventional study registered as NCT06915246 by VIVUS LLC, with 49 participants planned, started 2025-03-12 and due to reach its primary completion in 2027-03-31. Interventions recorded: VI-0609, BiCNU. Conditions listed: Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Carmustine, Hodgkin lymphoma, Non-Hodgkin lymphoma (all types), Cytotoxic chemotherapy.
Shares Carmustine, Non-Hodgkin lymphoma (all types), Cytotoxic chemotherapy.
Shares Carmustine, Non-Hodgkin lymphoma (all types), Cytotoxic chemotherapy.
Shares Carmustine, Hodgkin lymphoma.
Shares Carmustine, Hodgkin lymphoma, Non-Hodgkin lymphoma (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/